Literature DB >> 6504770

Formation of transendothelial channels in traumatic human brain edema.

O J Castejón.   

Abstract

The formation of incomplete transendothelial channels is reported in four cases of traumatic human brain injury complicated with subdural or epidural hematoma or hygroma. Such structures were observed coexisting with increased transendothelial vacuolar and vesicular transport. They appeared in the following manners: as electron lucent corridors formed by deep invaginations of luminal endothelial plasma membranes, as chained spheroidal or elongated vacuoles connected with the luminal and abluminal endothelial membranes, as a result of a combined process of membrane fusion and fission, as a large protein containing vacuole or a micropinocytotic vesicle occupying the entire width of peripheral endothelial cytoplasm, as abluminal profiles of dilated basement membrane expansions, extending their course to the vicinity of endothelial luminal plasma membrane. The endothelial junctions appeared intact in most cases. The transendothelial channels apparently represent a transcytosis response to the traumatic brain injury. They may provide specific cytoplasmic corridors of facilitated transport for edema formation, which incorporate the intraluminal capillary content, ferry it across the peripheral zone of endothelial cytoplasm and empty it at the abluminal surface, into the surrounding basement membrane, from where it floods the intercellular spaces of neighbouring neuropile. The albuminal transendothelial channels, formed by the dilated basement membrane bifurcations, might be a reverse shuttle for endogeneous substances moving from parenchymal clefts to blood as a capillary mechanism of edema resolution.

Entities:  

Mesh:

Year:  1984        PMID: 6504770     DOI: 10.1016/S0344-0338(84)80054-0

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  9 in total

1.  Blood-brain barrier pathophysiology in traumatic brain injury.

Authors:  Adam Chodobski; Brian J Zink; Joanna Szmydynger-Chodobska
Journal:  Transl Stroke Res       Date:  2011-12       Impact factor: 6.829

Review 2.  Involvement of bradykinin in brain edema development after ischemic stroke.

Authors:  Marina Dobrivojević; Katarina Špiranec; Aleksandra Sinđić
Journal:  Pflugers Arch       Date:  2014-04-23       Impact factor: 3.657

Review 3.  Brain oedema in focal ischaemia: molecular pathophysiology and theoretical implications.

Authors:  J Marc Simard; Thomas A Kent; Mingkui Chen; Kirill V Tarasov; Volodymyr Gerzanich
Journal:  Lancet Neurol       Date:  2007-03       Impact factor: 44.182

4.  Aquaporin and vascular diseases.

Authors:  Carla Loreto; Ester Reggio
Journal:  Curr Neuropharmacol       Date:  2010-06       Impact factor: 7.363

Review 5.  Role of aquaporin-4 in cerebral edema and stroke.

Authors:  Zsolt Zador; Shirley Stiver; Vincent Wang; Geoffrey T Manley
Journal:  Handb Exp Pharmacol       Date:  2009

Review 6.  Molecular pathophysiology of cerebral edema.

Authors:  Jesse A Stokum; Volodymyr Gerzanich; J Marc Simard
Journal:  J Cereb Blood Flow Metab       Date:  2015-11-16       Impact factor: 6.200

Review 7.  Neurogenic inflammation after traumatic brain injury and its potentiation of classical inflammation.

Authors:  Frances Corrigan; Kimberley A Mander; Anna V Leonard; Robert Vink
Journal:  J Neuroinflammation       Date:  2016-10-11       Impact factor: 8.322

8.  Blood-Brain Barrier Damage as the Starting Point of Leukoaraiosis Caused by Cerebral Chronic Hypoperfusion and Its Involved Mechanisms: Effect of Agrin and Aquaporin-4.

Authors:  Jing Huang; Junwen Li; Chao Feng; Xi Huang; Liping Wong; Xueyuan Liu; Zhiyu Nie; Gangming Xi
Journal:  Biomed Res Int       Date:  2018-02-26       Impact factor: 3.411

Review 9.  Inflammatory Regulation of CNS Barriers After Traumatic Brain Injury: A Tale Directed by Interleukin-1.

Authors:  Colleen N Bodnar; James B Watson; Emma K Higgins; Ning Quan; Adam D Bachstetter
Journal:  Front Immunol       Date:  2021-05-21       Impact factor: 8.786

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.